We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+25.52%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$9.53B
AUM Growth
+$1.89B
Cap. Flow
+$270M
Cap. Flow %
2.83%
Top 10 Hldgs %
11.36%
Holding
417
New
23
Increased
169
Reduced
161
Closed
41

Top Buys

Rank Stock Value
1
MEDP icon
Medpace
MEDP
+$39.8M
2
DAVA icon
Endava
DAVA
+$35.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$32.6M
4
HALO icon
Halozyme
HALO
+$30.3M
5
AZTA icon
Azenta
AZTA
+$29M

Top Sells

Rank Stock Value
1
QDEL icon
QuidelOrtho
QDEL
+$67.2M
2
VRTU
Virtusa Corporation
VRTU
+$45.8M
3
SITE icon
SiteOne Landscape Supply
SITE
+$40.6M
4
PODD icon
Insulet
PODD
+$37.5M
5
FIVE icon
Five Below
FIVE
+$25.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 15.98%
3 Industrials 14.75%
4 Consumer Discretionary 13.32%
5 Financials 12.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WD icon
226
Walker & Dunlop
WD
$1.45B
$8.54M 0.09%
92,853
+86,737
+1,418% +$6.43M
GPI icon
227
Group 1 Automotive
GPI
$3.17B
$8.12M 0.09%
61,910
+57,837
+1,420% +$6.95M
ARNA
228
DELISTED
Arena Pharmaceuticals Inc
ARNA
$7.91M 0.08%
102,897
-2,488
-2% -$186K
CBZ icon
229
CBIZ
CBZ
$2.96B
$7.84M 0.08%
294,560
+137,563
+88% +$3.39M
ZGNX
230
DELISTED
Zogenix, Inc.
ZGNX
$7.75M 0.08%
387,509
+206,350
+114% +$4.22M
GRBK icon
231
Green Brick Partners
GRBK
$3.02B
$7.71M 0.08%
335,990
-85,275
-20% -$1.78M
ALBO
232
DELISTED
Albireo Pharma Inc
ALBO
$7.7M 0.08%
205,226
+52,771
+35% +$1.92M
CSII
233
DELISTED
Cardiovascular Systems, Inc.
CSII
$7.69M 0.08%
175,667
-2,682
-2% -$101K
NOAH
234
Noah Holdings
NOAH
$588M
$7.62M 0.08%
159,351
+280
+0.2% +$9.05K
GTN icon
235
Gray Television
GTN
$498M
$7.05M 0.07%
394,292
+368,190
+1,411% +$5.84M
RDUS
236
DELISTED
Radius Recycling
RDUS
$7.04M 0.07%
220,670
+206,237
+1,429% +$5.08M
CMCO icon
237
Columbus McKinnon
CMCO
$557M
$7.01M 0.07%
182,436
+170,376
+1,413% +$6.41M
FCPT icon
238
Four Corners Property Trust
FCPT
$2.74B
$7.01M 0.07%
235,342
+219,932
+1,427% +$6.16M
CRL icon
239
Charles River Laboratories
CRL
$13.6B
$7M 0.07%
28,017
-10,620
-27% -$2.53M
USPH icon
240
US Physical Therapy
USPH
$1.22B
$6.9M 0.07%
+57,393
New +$5.79M
THC icon
241
Tenet Healthcare
THC
$21.5B
$6.83M 0.07%
171,129
+155,364
+985% +$5.01M
SIGI icon
242
Selective Insurance
SIGI
$5.59B
$6.8M 0.07%
101,459
+94,784
+1,420% +$5.68M
IRT icon
243
Independence Realty Trust
IRT
$3.96B
$6.77M 0.07%
504,410
+470,809
+1,401% +$6.02M
OYST
244
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$6.6M 0.07%
350,926
+68,219
+24% +$1.47M
BLD
245
DELISTED
TopBuild
BLD
$6.33M 0.07%
34,407
-1,034
-3% -$183K
DIS icon
246
Walt Disney
DIS
$178B
$6.26M 0.07%
34,556
+1,774
+5% +$255K
GWPH
247
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.18M 0.06%
53,573
-845
-2% -$94.7K
ICLR icon
248
Icon
ICLR
$12.9B
$6.12M 0.06%
31,371
-11,836
-27% -$2.31M
PLOW icon
249
Douglas Dynamics
PLOW
$981M
$6.06M 0.06%
141,779
+132,488
+1,426% +$5.09M
INVX
250
Innovex International
INVX
$2.13B
$5.95M 0.06%
200,854
-333,231
-62% -$9.47M
8 9
10
11 12

Similar funds

Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
ZIG
Zurich Insurance Group Zurich, Switzerland $12.7B AUM 53.57% 1-Year Est. Return
IMPI
Ilmarinen Mutual Pension Insurance Helsinki, Finland $12.7B AUM 16.27% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

GW&K Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, GW&K Investment Management held 417 positions worth $9.53B, up 25% from $7.64B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

GW&K Investment Management's Q4 2020 filing shows 23 new, 169 increased, 161 reduced and 41 closed positions. Its largest new stake was Medpace: 315,843 shares worth $44M. The largest sale was QuidelOrtho, an estimated $67.2M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.

  • GW&K Investment Management's largest Q4 2020 buy was Medpace: 315,843 shares worth $44M.
  • GW&K Investment Management added most to Endava in Q4 2020, an estimated $35.7M increase.
  • GW&K Investment Management's biggest Q4 2020 reduction was QuidelOrtho, cutting an estimated $67.2M.
  • GW&K Investment Management fully exited Aimmune Therapeutics in Q4 2020, selling an estimated $10.2M.
  • GW&K Investment Management's ten largest holdings make up 11% of its $9.53B portfolio in Q4 2020.
  • GW&K Investment Management opened 23 new positions and closed 41 in Q4 2020.
  • GW&K Investment Management's portfolio value rose 25% quarter-over-quarter to $9.53B.

Based on GW&K Investment Management's 13F filing for Q4 2020, filed 5 Feb 2021.